Brevan Howard Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.54M	Buy	+14,782	New	+$1.54M	0.01%	769
2025 Q1	–	Sell	-38,748	Closed	-$3.28M	–	1118
2024 Q4	$3.28M	Buy	38,748 +24,393	+170%	+$2.06M	0.02%	175
2024 Q3	$1.29M	Buy	14,355 +9,573	+200%	+$860K	0.01%	325
2024 Q2	$385K	Buy	+4,782	New	+$385K	﹤0.01%	645